| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |